Question 1

What are the potential side effects of these vaccines?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV clinical trial (NCT06919016). Contact the study team or your healthcare provider for specific answers.

Question 2

How often will I need to come in for visits during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV clinical trial (NCT06919016). Contact the study team or your healthcare provider for specific answers.

Question 3

What will happen if I experience an adverse reaction?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV clinical trial (NCT06919016). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my health be monitored throughout the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV clinical trial (NCT06919016). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any other treatment options available for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV clinical trial (NCT06919016). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I need to leave the study early?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV clinical trial (NCT06919016). Contact the study team or your healthcare provider for specific answers.

What this study is about